{"transactions":[{"id":744661,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:43:01.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264288/ownership.xml","form_type":"4"}},{"id":905543,"issuer":{"id":2963,"kind":"organization","name":"NORTHROP GRUMMAN CORP /DE/"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP & Chief Financial Officer"}}],"security":"Restricted Stock Rights","published_at":"2026-02-13T21:15:55.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":5362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Right (\"RSR\") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Right (\"RSR\") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSRs were granted under the 2024 LTISP on 2/11/26 and will vest on 2/12/29."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Total amount includes (i) 2,298 RSRs granted under the 2024 LTISP on 2/11/26 that will vest on 2/12/29; (ii) 1,532 RSRs granted under the 2024 LTISP on 2/11/26 that will vest on 2/11/27; and (iii) 1,532 RSRs granted under the 2024 LTISP on 2/11/26 that will vest on 2/11/28."}],"balance_after":5362,"derivative":{"underlying":"Common Stock","underlying_shares":5362},"source":{"system":"sec-edgar","filing":"0001628280-26-008122","document":"wk-form4_1771017352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133421/000162828026008122/wk-form4_1771017352.xml","form_type":"4"}},{"id":905542,"issuer":{"id":2963,"kind":"organization","name":"NORTHROP GRUMMAN CORP /DE/"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP & Chief Financial Officer"}}],"security":"Restricted Performance Stock Rights","published_at":"2026-02-13T21:15:55.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":4981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Performance Stock Right (\"RPSR\") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock.  The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period.  Grants awarded pursuant to Rule 16b-3(d)."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RPSRs acquired include 4,981 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (\"2024 LTISP) on 2/11/26 with a measurement period ending on 12/31/28."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Performance Stock Right (\"RPSR\") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock.  The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period.  Grants awarded pursuant to Rule 16b-3(d)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Performance Stock Right (\"RPSR\") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock.  The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period.  Grants awarded pursuant to Rule 16b-3(d)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RPSRs acquired include 4,981 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (\"2024 LTISP) on 2/11/26 with a measurement period ending on 12/31/28."}],"balance_after":4981,"derivative":{"underlying":"Common Stock","underlying_shares":4981},"source":{"system":"sec-edgar","filing":"0001628280-26-008122","document":"wk-form4_1771017352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133421/000162828026008122/wk-form4_1771017352.xml","form_type":"4"}},{"id":1119663,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:30:16.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":38.57,"expiration_date":"2035-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-25-083270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025083270/ownership.xml","form_type":"4"}},{"id":1142621,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T21:15:39.000Z","date":"2025-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":79943,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 19, 2024, by and among the Issuer, Capital One Financial Corporation (\"Capital One\"), and Vega Merger Sub, Inc. (\"Merger Sub\") (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, at the effective time of the merger (the \"Effective Time\") between the Issuer and Merger Sub (the \"Merger\"), each share of Issuer common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive 1.0192 shares of Capital One common stock (the \"Exchange Ratio\"). The Merger closed on May 18, 2025 (the \"Closing Date\").  The closing price of Capital One common stock on the New York Stock Exchange on the last trading day prior to the Closing Date was $197.22. All fractional shares were paid in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 42,023 shares of Issuer common stock in respect of restricted stock unit awards (the \"Issuer RSU Awards\"). Pursuant to the Merger Agreement, at the Effective Time, each Issuer RSU Award outstanding immediately prior to the Effective Time was converted into a Capital One restricted stock unit award in respect of that number of shares of Capital One common stock (rounded to the nearest whole share) equal to the product of (i) the total number of shares of Issuer common stock subject to the Issuer RSU Award immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, and which is otherwise be subject to the same terms and conditions as applied to the corresponding Issuer RSU Award immediately prior to the Effective Time."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 77.4 shares of Issuer common stock acquired under the Discover Financial Services Employee Stock Purchase Plan for the periods beginning January 1, 2025 and ending March 31, 2025 and beginning April 1, 2025 and ending May 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 19, 2024, by and among the Issuer, Capital One Financial Corporation (\"Capital One\"), and Vega Merger Sub, Inc. (\"Merger Sub\") (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, at the effective time of the merger (the \"Effective Time\") between the Issuer and Merger Sub (the \"Merger\"), each share of Issuer common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive 1.0192 shares of Capital One common stock (the \"Exchange Ratio\"). The Merger closed on May 18, 2025 (the \"Closing Date\").  The closing price of Capital One common stock on the New York Stock Exchange on the last trading day prior to the Closing Date was $197.22. All fractional shares were paid in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-074571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000095017025074571/ownership.xml","form_type":"4"}},{"id":1238560,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-02-28T22:35:05.000Z","date":"2025-02-26","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":44.8497,"value":313947.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase of shares in accordance with Issuer's trading policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.84 to $44.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000950170-25-030181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025030181/ownership.xml","form_type":"4"}},{"id":1284762,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T21:39:02.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1840,"price":201.09,"value":370005.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously granted restricted stock units."}],"balance_after":79866,"source":{"system":"sec-edgar","filing":"0000950170-25-013589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000095017025013589/ownership.xml","form_type":"4"}},{"id":1294419,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-27T23:54:32.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":14630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units pursuant to the Discover Financial Services 2023 Omnibus Incentive Plan."}],"balance_after":81706,"source":{"system":"sec-edgar","filing":"0000950170-25-009357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000095017025009357/ownership.xml","form_type":"4"}},{"id":1322825,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-23T22:16:20.000Z","date":"2024-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":11702,"price":169.27,"value":1980797.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld to satisfy the tax withholding obligation incurred in connection with the accelerated vesting of previously granted performance stock units and restricted stock units."}],"balance_after":67076,"source":{"system":"sec-edgar","filing":"0000950170-24-139707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000095017024139707/ownership.xml","form_type":"4"}},{"id":1322824,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-23T22:16:20.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":12109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired upon the accelerated vesting of performance stock units awarded in 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 190.89 shares aquired under the Discover Financial Services Employee Stock Purchase Plan (\"ESPP\") for the period beginning January 1, 2024 and ending September 30, 2024. No shares were acquired under the ESPP for the period beginning October 1, 2023 and ending December 31, 2023."}],"balance_after":78778,"source":{"system":"sec-edgar","filing":"0000950170-24-139707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000095017024139707/ownership.xml","form_type":"4"}},{"id":1496685,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:15:05.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on May 31, 2024; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":54.06,"expiration_date":"2034-05-30","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-24-067324","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024067324/ownership.xml","form_type":"4"}},{"id":1619338,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-26T22:17:03.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":9051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Special retention award of restricted stock units pursuant to the Discover Financial Services 2023 Omnibus Incentive Plan."}],"balance_after":66478,"source":{"system":"sec-edgar","filing":"0000950170-24-020305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000095017024020305/ownership.xml","form_type":"4"}},{"id":1619337,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-26T22:17:03.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":29324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units pursuant to the Discover Financial Services 2023 Omnibus Incentive Plan."}],"balance_after":57427,"source":{"system":"sec-edgar","filing":"0000950170-24-020305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000095017024020305/ownership.xml","form_type":"4"}},{"id":1658813,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-06T02:27:28.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":12290,"price":106.56,"value":1309622.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously granted performance stock units and restricted stock units."}],"balance_after":28103,"source":{"system":"sec-edgar","filing":"0001209191-24-002874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919124002874/doc4.xml","form_type":"4"}},{"id":1658812,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-06T02:27:28.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":21801,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40393,"source":{"system":"sec-edgar","filing":"0001209191-24-002874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919124002874/doc4.xml","form_type":"4"}},{"id":1658811,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-06T02:22:08.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":12290,"price":106.56,"value":1309622.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously granted performance stock units and restricted stock units."}],"balance_after":28103,"source":{"system":"sec-edgar","filing":"0001209191-24-002867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919124002867/doc4.xml","form_type":"4"}},{"id":1658810,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-06T02:22:08.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":21801,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40393,"source":{"system":"sec-edgar","filing":"0001209191-24-002867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919124002867/doc4.xml","form_type":"4"}},{"id":1666472,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-30T21:24:05.000Z","date":"2024-01-26","kind":"sale","planned":false,"acquired":false,"shares":35191,"price":106.51,"value":3748193.41,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $106.31 to $106.71. The reporting person provided to the issuer, and will provide any security holder of Discover Financial Services or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 244.43 shares acquired under the Discover Financial Services Employee Stock Purchase Plan for the period beginning January 1, 2023 and ending on September 30, 2023."}],"balance_after":18592,"source":{"system":"sec-edgar","filing":"0001209191-24-002412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919124002412/doc4.xml","form_type":"4"}},{"id":1860525,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T21:34:49.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":62.59,"expiration_date":"2033-06-08","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-23-035977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123035977/doc4.xml","form_type":"4"}},{"id":1990314,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-27T21:06:21.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":9960,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53539,"source":{"system":"sec-edgar","filing":"0001209191-23-013158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919123013158/doc4.xml","form_type":"4"}},{"id":2032941,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T21:17:41.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":14083,"price":115.83,"value":1631233.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously granted performance stock units and restricted stock units."}],"balance_after":43579,"source":{"system":"sec-edgar","filing":"0001209191-23-006820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919123006820/doc4.xml","form_type":"4"}},{"id":2032940,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T21:17:41.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":25196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 190.5845 shares acquired under the Discover Financial Services Employee Stock Purchase Plan for the period beginning July 1, 2022 and ending on December 31, 2022."}],"balance_after":57662,"source":{"system":"sec-edgar","filing":"0001209191-23-006820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919123006820/doc4.xml","form_type":"4"}},{"id":2195775,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-03T21:35:32.000Z","date":"2022-08-01","kind":"tax_withholding","acquired":false,"shares":1752,"price":102.22,"value":179089.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 75.4574 shares acquired under the Discover Financial Services Employee Stock Purchase Plan for the period beginning April 1, 2022 and ending on June 30, 2022."}],"balance_after":32275.4574,"source":{"system":"sec-edgar","filing":"0001209191-22-044279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919122044279/doc4.xml","form_type":"4"}},{"id":2235960,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T21:41:54.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders."}],"balance_after":12000,"derivative":{"exercise_price":71.7,"expiration_date":"2032-06-09","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-036045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122036045/doc4.xml","form_type":"4"}},{"id":2365312,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T22:53:21.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":7339,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33952,"source":{"system":"sec-edgar","filing":"0001209191-22-014228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919122014228/doc4.xml","form_type":"4"}},{"id":2388478,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-17T22:11:09.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":4443,"price":127.946,"value":568464.078,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $127.900 to $128.116. The reporting person provided to the issuer, and will provide any security holder of Discover Financial Services or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request"}],"balance_after":26613,"source":{"system":"sec-edgar","filing":"0001209191-22-010877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919122010877/doc4.xml","form_type":"4"}},{"id":2413801,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T22:49:33.000Z","date":"2022-02-01","kind":"tax_withholding","acquired":false,"shares":2079,"price":118.02,"value":245363.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously granted restricted stock units."}],"balance_after":31056,"source":{"system":"sec-edgar","filing":"0001209191-22-006912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000120919122006912/doc4.xml","form_type":"4"}},{"id":2617730,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-03T21:31:53.000Z","date":"2021-08-01","kind":"tax_withholding","acquired":false,"shares":1752,"price":124.32,"value":217808.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously-granted restricted stock units."}],"balance_after":33135,"source":{"system":"sec-edgar","filing":"0001567619-21-014364","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000156761921014364/doc1.xml","form_type":"4"}},{"id":2670219,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T21:38:24.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2021 with respect to 10,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2021; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2022 Annual General Meeting of Shareholders."}],"balance_after":10000,"derivative":{"exercise_price":123.71,"expiration_date":"2031-06-10","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-040295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121040295/doc4.xml","form_type":"4"}},{"id":2839315,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-24T00:18:46.000Z","date":"2021-02-19","kind":"grant","acquired":false,"shares":9690,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34887,"source":{"system":"sec-edgar","filing":"0001140361-21-005893","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000114036121005893/form4.xml","form_type":"4"}},{"id":2881833,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:40:18.000Z","date":"2021-02-01","kind":"tax_withholding","acquired":false,"shares":1146,"price":82.19,"value":94189.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously-granted restricted stock units."}],"balance_after":25197,"source":{"system":"sec-edgar","filing":"0001140361-21-003306","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000114036121003306/form4.xml","form_type":"4"}},{"id":3071346,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-03T22:33:31.000Z","date":"2020-08-01","kind":"tax_withholding","acquired":false,"shares":1159,"price":49.43,"value":57289.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Number of shares withheld to pay the tax withholding obligation incurred in connection with the vesting of previously-granted restricted stock units."}],"balance_after":26343,"source":{"system":"sec-edgar","filing":"0000905148-20-000852","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000090514820000852/form4.xml","form_type":"4"}},{"id":3110589,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T20:33:17.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2020 with respect to 15,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2020; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2021 Annual General Meeting of Shareholders."}],"balance_after":15000,"derivative":{"exercise_price":59.7,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-036619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120036619/doc4.xml","form_type":"4"}},{"id":3301423,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-27T23:28:56.000Z","date":"2020-01-27","kind":"purchase","acquired":true,"shares":3377,"price":73.8356,"value":249342.8212,"ownership":{"direct":true},"balance_after":27502,"source":{"system":"sec-edgar","filing":"0000905148-20-000170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000090514820000170/form4.xml","form_type":"4"}},{"id":3303009,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-24T21:10:48.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":11198,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24125,"source":{"system":"sec-edgar","filing":"0000905148-20-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000090514820000130/form4.xml","form_type":"4"}},{"id":3408997,"issuer":{"id":13531,"kind":"organization","name":"Discover Financial Services","symbol":"DFS"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-20T20:35:56.000Z","date":"2019-09-18","kind":"grant","acquired":true,"shares":11861,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12927,"source":{"system":"sec-edgar","filing":"0000905148-19-000863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000090514819000863/form4.xml","form_type":"4"}},{"id":3491481,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T21:05:18.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2019 with respect to 30,000 Common Shares with 100% of the shares vesting in 36 equal monthly installments."}],"balance_after":30000,"derivative":{"exercise_price":43.52,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-19-016846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319016846/doc4.xml","form_type":"4"}},{"id":4005679,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-Qualified Stock Option","published_at":"2018-03-08T17:31:26.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":56615,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":44.51,"underlying":"Common Stock","underlying_shares":56615},"source":{"system":"sec-edgar","filing":"0001127602-18-010664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218010664/form4.xml","form_type":"4"}},{"id":4005678,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-Qualified Stock Option","published_at":"2018-03-08T17:31:26.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":113230,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":44.51,"underlying":"Common Stock","underlying_shares":113230},"source":{"system":"sec-edgar","filing":"0001127602-18-010664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218010664/form4.xml","form_type":"4"}},{"id":4005677,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2018-03-08T17:31:26.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":42727,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one Share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":42727},"source":{"system":"sec-edgar","filing":"0001127602-18-010664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218010664/form4.xml","form_type":"4"}},{"id":4005676,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2018-03-08T17:31:26.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":14230,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one Share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14230},"source":{"system":"sec-edgar","filing":"0001127602-18-010664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218010664/form4.xml","form_type":"4"}},{"id":4005675,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-03-08T17:31:26.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":5951.011,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 454.9542 shares acquired under the Company's Employee Stock Purchase Plan on March 6, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of January 21, 2018 (the \"Merger Agreement\"), between the Company, Sanofi, a French soci?t? anonyme (the \"Parent\"), and Blink Acquisition Corp. (\"Merger Sub\"), on March 8, 2018, Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\").  Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive $105.00 in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-18-010664","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218010664/form4.xml","form_type":"4"}},{"id":4054909,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2018-02-15T22:24:29.000Z","date":"2018-02-14","kind":"exercise","acquired":false,"shares":7114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."}],"balance_after":14230,"derivative":{"underlying":"Common Stock","underlying_shares":7114},"source":{"system":"sec-edgar","filing":"0001127602-18-006441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218006441/form4.xml","form_type":"4"}},{"id":4054908,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-02-15T22:24:29.000Z","date":"2018-02-14","kind":"tax_withholding","acquired":false,"shares":2118,"price":103.52,"value":219255.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":5496.0568,"source":{"system":"sec-edgar","filing":"0001127602-18-006441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218006441/form4.xml","form_type":"4"}},{"id":4054907,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-02-15T22:24:29.000Z","date":"2018-02-14","kind":"exercise","acquired":true,"shares":7114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 500.0568 shares acquired under the Company's Employee Stock Purchase Plan on April 5, 2017 and July 6, 2017."}],"balance_after":7614.0568,"source":{"system":"sec-edgar","filing":"0001127602-18-006441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218006441/form4.xml","form_type":"4"}},{"id":4079241,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2018-02-02T22:21:05.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":42727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning on January 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning on January 31, 2019."}],"balance_after":42727,"derivative":{"underlying":"Common Stock","underlying_shares":42727},"source":{"system":"sec-edgar","filing":"0001127602-18-003823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760218003823/form4.xml","form_type":"4"}},{"id":4371546,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-03-27T20:31:31.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":113230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the third anniversary of the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."}],"balance_after":113230,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":113230},"source":{"system":"sec-edgar","filing":"0001127602-17-012955","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760217012955/form4a.xml","form_type":"4/A","original_submission_date":"2017-02-16"}},{"id":4371545,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-03-27T20:31:31.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":56615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning on February 14, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."}],"balance_after":56615,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":56615},"source":{"system":"sec-edgar","filing":"0001127602-17-012955","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760217012955/form4a.xml","form_type":"4/A","original_submission_date":"2017-02-16"}},{"id":4442661,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2017-02-16T21:41:11.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":21344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."}],"balance_after":21344,"derivative":{"underlying":"Common Stock","underlying_shares":21344},"source":{"system":"sec-edgar","filing":"0001127602-17-006623","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760217006623/form4.xml","form_type":"4"}},{"id":4442660,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-02-16T21:41:11.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":113028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the third anniversary of the date of grant."}],"balance_after":113028,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":113028},"source":{"system":"sec-edgar","filing":"0001127602-17-006623","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760217006623/form4.xml","form_type":"4"}},{"id":4442659,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-02-16T21:41:11.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":56514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments beginning on February 14, 2018."}],"balance_after":56514,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":56514},"source":{"system":"sec-edgar","filing":"0001127602-17-006623","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610732/000112760217006623/form4.xml","form_type":"4"}}]}